Cardiomyopathy Trial, Recruiting (NCT06814990)

Cardiomyopathy Trial, Recruiting NCT06814990 Sponsor: Stephanie Gräger Condition: Cardiomyopathy

Printed from Voxsanity (voxsanity.com.au) — NCT06814990 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cardiomyopathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 to 99 years old
People who have given written consent to participate
People who have been diagnosed with decompensated liver cirrhosis (a serious stage of liver scarring where the liver is no longer functioning well), confirmed through clinical assessment, imaging, or blood tests
People who are already scheduled to receive a planned TIPSS procedure (a type of internal shunt placed in the liver to reduce blood pressure) at the Johann Ulrich Hospital (JUH) as part of their normal care

Who may not be able to join:

People who are pregnant
People who have implants in their body that are not safe for MRI scans (such as certain metal devices or pacemakers)
People who are unable to have an MRI scan for medical or personal reasons, such as claustrophobia, being unable to lie flat, or being unable to follow breathing instructions during the scan
People who are in a critical medical condition or who are unable to cooperate with the study requirements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Stephanie Gräger, Jena University Hospital

Phone: +4936419324800

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06814990

Sponsor: Stephanie Gräger

Phase: Not Applicable

Status: Recruiting

Condition: Cardiomyopathy

Trial contact: +4936419324800

More information: https://clinicaltrials.gov/study/NCT06814990

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 to 99 years old
People who have given written consent to participate
People who have been diagnosed with decompensated liver cirrhosis (a serious stage of liver scarring where the liver is no longer functioning well), confirmed through clinical assessment, imaging, or blood tests
People who are already scheduled to receive a planned TIPSS procedure (a type of internal shunt placed in the liver to reduce blood pressure) at the Johann Ulrich Hospital (JUH) as part of their normal care

Who may not be able to join:

People who are pregnant
People who have implants in their body that are not safe for MRI scans (such as certain metal devices or pacemakers)
People who are unable to have an MRI scan for medical or personal reasons, such as claustrophobia, being unable to lie flat, or being unable to follow breathing instructions during the scan
People who are in a critical medical condition or who are unable to cooperate with the study requirements

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Stephanie Gräger

Registry

ClinicalTrials.gov

Start date

19 April 2024

Est. completion

19 April 2027

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Determination of the frequency of occurrence of cardiac decompensation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov